USFDA completes inspection at Indoco Remedies’ Goa Plant II

16 Oct 2019 Evaluate

US Food and Drug Administration (USFDA) has successfully concluded inspection at Indoco Remedies’ sterile manufacturing facility in Goa (Plant II) from October 7 to October 15, 2019.

The inspection ended with 2 observations, neither of these are related to Data Integrity or the core Quality Management System and the company will respond to the FDA within the stipulated time. The site continues to maintain its VAI status.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

329.00 4.55 (1.40%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.